Silvestri Cristoforo
Membre chercheur régulier
Professeur adjoint
Université Laval
Thèmes de recherche
Thème 3 - Alimentation et bien-être
Thème 4 - Personnalisation de la nutrition
Mots clés
microbiome
lipids
metabolism
obesity
endocannabinoid
fats
Coordonnées
- Université Laval
Professeur adjoint
Faculté de médecine
Département de médecine
Pavillon Ferdinand-Vandry - Local 4211; Centre de recherche de l'Institut de cardiologie et de pneumologie de Québec - Local A3152
1050 avenue de la Médecine
Québec (Québec) G1V 0A6
Canada
2725 chemin Ste-Foy
Québec (Québec) G1V 4G5
Canada
Expertises
Les endocannabinoïdes sont des lipides bioactifs qui émettent des signaux par l’intermédiaire de récepteurs cannabinoïdes, qui sont activés par le composant psychoactif de la marijuana : le THC. Le Dr Cristoforo Silvestri se concentre sur l’impact du système endocannabinoïde et des molécules connexes sur le métabolisme et l’obésité, y compris le développement du tissu adipeux, la régulation du métabolisme du glucose et des lipides et la régulation des hormones de modification du métabolisme et des adipokines.
Endocannbinoids are bioactive lipids that signal through cannabinoid receptors, which are activated by the psychoactive component of marijuana: THC. Dr. Cristoforo Silvestri focuses on the impact of the endocannabinoid system and related molecules on metabolism and obesity, including the development of adipose tissue, the regulation of glucose and lipid metabolism, and the regulation of metabolic modifying hormones and adipokines.
Formation
Doctorate - Biology - University of Toronto
Bachelor's Honours - Biology - York University
En savoir plus
Abolghasemi, A., Manca, C., Iannotti, F. A., Shen, M., Leblanc, N., Lacroix, S., Martin, C., Flamand, N., Di Marzo, V., & Silvestri, C. (2021). Investigation into the effects of vitamin D on olanzapine-caused metabolic side effects: Focus on the endocannabinoidome—Gut microbiome axis. International Journal of Molecular Sciences. 2021 Nov, 22(22), 12361e.
Archambault, A.-S., Tinto, F., Dumais, É., Rakotoarivelo, V., Kostrzewa, M., Plante, P.-L., Martin, C., Simard, M., Silvestri, C., Roxane, P., Laviolette, M., Boulet, L.-P., Vitale, R. M., Ligresti, A., Di Marzo, V., & Flamand, N. (2021). Biosynthesis of the novel endogenous 15-lipoxygenase metabolites N-13-hydroxy-octodecadienoyl-ethanolamine and 13-hydroxy-octodecadienoyl-glycerol by human neutrophils and eosinophils. Cells. 2021 Sep 5;10(9):2322
Ayoub, S., Piscitelli, F., Silvestri, C., Limebeer, C. L., Rock, E. M., Smoum, R., Farag, M., de Almeida, H., Sullivan, M., Lacroix, S., Boubertakh, B., Nallabelli, N., Lichtman, A. H., Leri, F., Mechoulam, R., Di Marzo, V., & Parker, L. A. (2021). Spontaneous and naloxone-precipitated withdrawal behaviors from chronic opiates are accompanied by changes in N-Oleoylglycine and N-Oleoylalanine levels in the brain and ameliorated by treatment with these mediators. Frontiers in Pharmacology. 2021 Sep 15;12:706703
Suriano, F., Manca, C., Flamand, N., Depommier, C., Van Hul, M., Delzenne, N. M., Silvestri, C., Cani, P. D., & Di Marzo, V. (2021). Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota. BBA – Molecular and Cell Biology of Lipids. 2022 Jan;1867(1):159056
Manca, C., Lacroix, S., Perusse, F., Flamand, N., Chagnon, Y., Drapeau, V., Tremblay, A., Di Marzo, V., & Silvestri, C. (2021). Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproduction-Aged Women Living with Overweight and Obesity. Biomedicines 2021 Sep 17;9(9):1246; https://doi.org/10.3390/biomedicines9091246
Bertrand, J. A., Woodward, D. F., Sherwood, J. M., Spenlehauer, A., Silvestri, C., Piscitelli, F., Marzo, V. D., Yamazaki, M., Sakimura, K., Inoue, Y., Watanabe, K., & Overby, D. R. (2021). Deletion of the gene encoding prostamide/prostaglandin F synthase reveals an important role in regulating intraocular pressure. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 165, 102235. https://doi.org/10.1016/j.plefa.2020.102235
Depommier, C., Vitale, R. M., Iannotti, F. A., Silvestri, C., Flamand, N., Druart, C., Everard, A., Pelicaen, R., Maiter, D., Thissen, J.-P., Loumaye, A., Hermans, M. P., Delzenne, N. M., de Vos, W. M., Di Marzo, V., & Cani, P. D. (2021). Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists. Cells, 10(1), 185. https://doi.org/10.3390/cells10010185
Lefort, C., Roumain, M., Van Hul, M., Rastelli, M., Manco, R., Leclercq, I., Delzenne, N. M., Marzo, V. D., Flamand, N., Luquet, S., Silvestri, C., Muccioli, G. G., & Cani, P. D. (2020). Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism. Cells, 9(5), E1247. https://doi.org/10.3390/cells9051247
Dione, N., Lacroix, S., Taschler, U., Deschênes, T., Abolghasemi, A., Leblanc, N., Di Marzo, V., & Silvestri, C. (2020). Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota. Cells, 9(12), 2705. https://doi.org/10.3390/cells9122705
Manca, C., Boubertakh, B., Leblanc, N., Deschênes, T., Lacroix, S., Martin, C., Houde, A., Veilleux, A., Flamand, N., Muccioli, G. G., Raymond, F., Cani, P. D., Marzo, V. D., & Silvestri, C. (2020). Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. Journal of Lipid Research, 61(1), 70–85. https://doi.org/10.1194/jlr.RA119000424
Manca, C., Shen, M., Boubertakh, B., Martin, C., Flamand, N., Silvestri, C., & Di Marzo, V. (2020). Alterations of brain endocannabinoidome signaling in germ-free mice. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 1865(12), 158786. https://doi.org/10.1016/j.bbalip.2020.158786
Silvestri, C., Pagano, E., Lacroix, S., Venneri, T., Cristiano, C., Calignano, A., Parisi, O. A., Izzo, A. A., Di Marzo, V., & Borrelli, F. (2020). Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.585096
Di Marzo, V., & Silvestri, C. (2019). Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome. Nutrients, 11(8), 1956. https://doi.org/10.3390/nu11081956 – (review article)
Lacroix, S., Pechereau, F., Leblanc, N., Boubertakh, B., Houde, A., Martin, C., Flamand, N., Silvestri, C., Raymond, F., Marzo, V. D., & Veilleux, A. (2019). Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice. MSystems, 4(6). https://doi.org/10.1128/mSystems.00407-19
Piscitelli, F., & Silvestri, C. (2019). Role of the endocannabinoidome in human and mouse atherosclerosis. Current Pharmaceutical Design, 25. https://doi.org/10.2174/1381612825666190826162735
Veilleux, A., Di Marzo, V., & Silvestri, C. (2019). The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus. Current Diabetes Reports, 19(11), 117. https://doi.org/10.1007/s11892-019-1248-9
Janssens, A., Silvestri, C., Martella, A., Vanoevelen, J. M., Di Marzo, V., & Voets, T. (2018). Δ9-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6. Pharmacological Research, 136, 83–89. https://doi.org/10.1016/j.phrs.2018.08.021
Ligresti, A., Silvestri, C., Vitale, R. M., Martos, J., Piscitelli, F., Wang, J., Allarà, M., Carling, R., Luongo, L., Guida, F., Illiano, A., Amoresano, A., Maione, S., Amodeo, P., Woodward, D., Di Marzo, V., & Marino, G. (2018). FAAH-catalyzed C-C bond cleavage of a new multi-target analgesic drug. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.8b00315
Vitale, R. M., D’Aniello, E., Gorbi, S., Martella, A., Silvestri, C., Giuliani, M. E., Fellous, T., Gentile, A., Carbone, M., Cutignano, A., Grauso, L., Magliozzi, L., Polese, G., D’Aniello, B., Defranoux, F., Felline, S., Terlizzi, A., Calignano, A., Regoli, F., … Mollo, E. (2018). Fishing for Targets of Alien Metabolites: A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Agonist from a Marine Pest. Marine Drugs, 16(11), 431. https://doi.org/10.3390/md16110431
Sentinel North Partner Research Chair on the Gut Microbiome-Endocannabinoid System as an Integrator of Extreme Environmental Influences on Bioenergetics
Associated with the Canada Excellence Research Chair on Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND)